Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Rizzieri

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Bone Marrow Transplantation|December 6, 2011
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsD-F Chen, V K Prasad, G Broadwater, et al.
Leukemia|July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaF J Giles, R T Swords, A Nagler, et al.
Leukemia|September 12, 2008
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemiaJ B Weinberg, A D Volkheimer, M Mihovilovic, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Bone Marrow Transplantation|December 6, 2011
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsD-F Chen, V K Prasad, G Broadwater, et al.
Leukemia|July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaF J Giles, R T Swords, A Nagler, et al.
Leukemia|September 12, 2008
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemiaJ B Weinberg, A D Volkheimer, M Mihovilovic, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Pageof 3